The	the	O	O
attenuating	attenuating	O	O
effect	effect	O	O
of	of	O	O
carteolol	carteolol	B_chemical	O
hydrochloride	hydrochloride	I_chemical	O
,	,	O	O
a	a	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
antagonist	antagonist	O	O
,	,	O	O
on	on	O	O
neuroleptic-induced	neuroleptic-induced	O	O
catalepsy	catalepsy	O	S_disease
in	in	O	O
rats	rats	O	O
.	.	O	O

It	it	O	O
is	is	O	O
known	known	O	O
that	that	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
antagonists	antagonists	O	O
are	are	O	O
effective	effective	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
akathisia	akathisia	O	S_disease
,	,	O	O
one	one	O	O
of	of	O	O
the	the	O	O
extrapyramidal	extrapyramidal	O	S_disease
side	side	O	B_disease
effects	effects	O	I_disease
that	that	O	O
occur	occur	O	O
during	during	O	O
neuroleptic	neuroleptic	O	O
treatment	treatment	O	O
.	.	O	O

Neuroleptic-induced	neuroleptic-induced	O	O
catalepsy	catalepsy	O	S_disease
,	,	O	O
a	a	O	O
model	model	O	O
of	of	O	O
neuroleptic-induced	neuroleptic-induced	O	O
extrapyramidal	extrapyramidal	O	S_disease
side	side	O	B_disease
effects	effects	O	I_disease
,	,	O	O
was	was	O	O
considered	considered	O	O
suitable	suitable	O	O
as	as	O	O
a	a	O	O
model	model	O	O
for	for	O	O
predicting	predicting	O	O
neuroleptic-induced	neuroleptic-induced	O	O
akathisia	akathisia	O	S_disease
in	in	O	O
humans	humans	O	O
,	,	O	O
although	although	O	O
neuroleptic-induced	neuroleptic-induced	O	O
catalepsy	catalepsy	O	S_disease
was	was	O	O
not	not	O	O
considered	considered	O	O
a	a	O	O
specific	specific	O	O
test	test	O	O
for	for	O	O
neuroleptic-induced	neuroleptic-induced	O	O
akathisia	akathisia	O	S_disease
.	.	O	O

Therefore	therefore	O	O
,	,	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
carteolol	carteolol	S_chemical	O
,	,	O	O
a	a	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
antagonist	antagonist	O	O
,	,	O	O
on	on	O	O
haloperidol-induced	haloperidol-induced	O	O
catalepsy	catalepsy	O	S_disease
in	in	O	O
rats	rats	O	O
were	were	O	O
behaviorally	behaviorally	O	O
studied	studied	O	O
and	and	O	O
compared	compared	O	O
with	with	O	O
those	those	O	O
of	of	O	O
propranolol	propranolol	S_chemical	O
and	and	O	O
biperiden	biperiden	S_chemical	O
,	,	O	O
a	a	O	O
muscarinic	muscarinic	S_chemical	O
receptor	receptor	O	O
antagonist	antagonist	O	O
.	.	O	O

Carteolol	carteolol	S_chemical	O
,	,	O	O
as	as	O	O
well	well	O	O
as	as	O	O
propranolol	propranolol	S_chemical	O
and	and	O	O
biperiden	biperiden	S_chemical	O
,	,	O	O
inhibited	inhibited	O	O
the	the	O	O
haloperidol-induced	haloperidol-induced	O	O
catalepsy	catalepsy	O	S_disease
.	.	O	O

The	the	O	O
inhibitory	inhibitory	O	O
effect	effect	O	O
of	of	O	O
carteolol	carteolol	S_chemical	O
was	was	O	O
almost	almost	O	O
comparable	comparable	O	O
to	to	O	O
that	that	O	O
of	of	O	O
propranolol	propranolol	S_chemical	O
,	,	O	O
but	but	O	O
was	was	O	O
weaker	weaker	O	O
than	than	O	O
that	that	O	O
of	of	O	O
biperiden	biperiden	S_chemical	O
.	.	O	O

Carteolol	carteolol	S_chemical	O
did	did	O	O
not	not	O	O
evoke	evoke	O	O
postsynaptic	postsynaptic	O	O
dopamine	dopamine	S_chemical	O
receptor-stimulating	receptor-stimulating	O	O
behavioral	behavioral	O	O
signs	signs	O	O
such	such	O	O
as	as	O	O
stereotypy	stereotypy	O	S_disease
and	and	O	O
hyperlocomotion	hyperlocomotion	O	S_disease
in	in	O	O
rats	rats	O	O
.	.	O	O

Carteolol	carteolol	S_chemical	O
did	did	O	O
not	not	O	O
antagonize	antagonize	O	O
the	the	O	O
inhibitory	inhibitory	O	O
effects	effects	O	O
of	of	O	O
haloperidol	haloperidol	S_chemical	O
on	on	O	O
apomorphine-induced	apomorphine-induced	O	O
stereotypy	stereotypy	O	S_disease
and	and	O	O
locomotor	locomotor	O	O
activity	activity	O	O
in	in	O	O
rats	rats	O	O
.	.	O	O

In	in	O	O
addition	addition	O	O
,	,	O	O
carteolol	carteolol	S_chemical	O
did	did	O	O
not	not	O	O
evoke	evoke	O	O
5-HT1A	5-ht1a	O	O
receptor-stimulating	receptor-stimulating	O	O
behavioral	behavioral	O	O
signs	signs	O	O
such	such	O	O
as	as	O	O
flat	flat	O	O
body	body	O	O
posture	posture	O	O
and	and	O	O
forepaw	forepaw	O	O
treading	treading	O	O
and	and	O	O
did	did	O	O
not	not	O	O
inhibit	inhibit	O	O
5-hydroxytryptophan-induced	5-hydroxytryptophan-induced	O	O
head	head	O	O
twitch	twitch	O	O
in	in	O	O
rats	rats	O	O
.	.	O	O

Finally	finally	O	O
,	,	O	O
carteolol	carteolol	S_chemical	O
did	did	O	O
not	not	O	O
inhibit	inhibit	O	O
physostigmine-induced	physostigmine-induced	O	O
lethality	lethality	O	O
in	in	O	O
rats	rats	O	O
.	.	O	O

These	these	O	O
results	results	O	O
strongly	strongly	O	O
suggest	suggest	O	O
that	that	O	O
carteolol	carteolol	S_chemical	O
improves	improves	O	O
haloperidol-induced	haloperidol-induced	O	O
catalepsy	catalepsy	O	S_disease
via	via	O	O
its	its	O	O
beta-adrenoceptor	beta-adrenoceptor	O	O
antagonistic	antagonistic	O	O
activity	activity	O	O
and	and	O	O
is	is	O	O
expected	expected	O	O
to	to	O	O
be	be	O	O
effective	effective	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
akathisia	akathisia	O	S_disease
without	without	O	O
attenuating	attenuating	O	O
neuroleptic-induced	neuroleptic-induced	O	O
antipsychotic	antipsychotic	B_chemical	O
effects	effects	I_chemical	O
due	due	O	O
to	to	O	O
its	its	O	O
postsynaptic	postsynaptic	O	O
dopamine	dopamine	S_chemical	O
receptor	receptor	O	O
antagonistic	antagonistic	O	O
activity	activity	O	O
.	.	O	O

